Last reviewed · How we verify
Cleanser
Cleanser, marketed by Dr.dr.Irma Bernadette, SpKK (K), is an acne treatment currently available in the market. The drug's key composition patent is set to expire in 2028, providing a period of exclusivity and potential market protection. The primary risk is the lack of disclosed revenue and key trial results, which may limit investor confidence and competitive positioning.
At a glance
| Generic name | Cleanser |
|---|---|
| Sponsor | Dr.dr.Irma Bernadette, SpKK (K) |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
- Acne Treatment
- Prevention of New Acne Blemishes
Common side effects
- Dryness
- Fissuring of paranasal and infraorbital areas
- Erythema
- Stinging
Serious adverse events
- Hypersensitivity (localized contact dermatitis)
Key clinical trials
- Omega-3 Supplementation vs Demodex vs Eyelid Cleanser for Pediatric Chalazia (PHASE2)
- SHAPE Pilot Trial: Skin Health and Allergy Prevention Exposure (NA)
- A 16-week Clinical Study Investigating a Dark Spot Corrector Serum in Women With Moderate Discrete Hyperpigmentation (NA)
- Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients (PHASE4)
- Bacterial Decolonization Plus Intraoperative Angiography for Soft Tissue Sarcomas Receiving Preoperative Radiotherapy (CONCERTO) (PHASE2)
- Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic Dermatitis (NA)
- Clear Aligner Cleaning: Brushing, Chlorhexidine, and BlueM Effects on Oral Microbial Ecology and Periodontal Indices (NA)
- A Clinical In-Use Evaluation to Assess the Tolerability and Efficacy of a Moisturizer on Acne Prone Skin (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cleanser CI brief — competitive landscape report
- Cleanser updates RSS · CI watch RSS
- Dr.dr.Irma Bernadette, SpKK (K) portfolio CI